Catalytic enantioselective reductive alkynylation of amides enables one-pot syntheses of pyrrolidine, piperidine and indolizidine alkaloids.

The primary objective in synthetic organic chemistry is to develop highly efficient, selective, and versatile synthetic methodologies, which are essential for discovering new drug candidates and agrochemicals. In this study, we present a unified strategy for a one-pot, catalytic enantioselective synthesis of α-alkyl and α,α'-dialkyl pyrrolidine, piperidine, and indolizidine alkaloids using readily available amides and alkynes. This synthesis is enabled by the identification and development of an Ir/Cu/N-PINAP catalyzed highly enantioselective and chemoselective reductive alkynylation of α-unbranched aliphatic amides, which serves as the key reaction.

Synthesis of lignin nanoparticle‑manganese dioxide complex and its adsorption of methyl orange.

Lignin nanoparticles (LNPs) were synthesized using an anti-solvent method and subsequently loaded with manganese dioxide (MnO) via potassium permanganate treatment, resulting in the formation of MnO@LNPs. An extensive investigation was conducted to elucidate the influence of MnO@LNPs on the decolorization of methyl orange solution. The LNPs were successfully obtained by adjusting the preparation parameters, yielding particles exhibited average sizes ranging from 300 to 600 nm, and the synthesis process exhibited a high yield of up to 87.

Multicatalysis protocol enables direct and versatile enantioselective reductive transformations of secondary amides.

The catalytic asymmetric geminal bis-nucleophilic addition to nonreactive functional groups is a type of highly desirable yet challenging transformation in organic chemistry. Here, we report the first catalytic asymmetric reductive/deoxygenative alkynylation of secondary amides. The method is based on a multicatalysis strategy that merges iridium/copper relay catalysis with organocatalysis.

Primary small cell neuroendocrine carcinoma of the oral cavity: A case report and review of the literature.

Small cell neuroendocrine carcinoma (SNEC) of the oral cavity is a rare and distinctive tumor with aggressive clinical behavior. Thus far, only a small number of cases have been reported and no definitive standard treatment strategy has been determined. The current study reports a case of oral SNEC arising in the lower gingiva in a 73-year-old male.